Control Strategies in Pharmaceutical Development and Manufacturing II | AIChE

Control Strategies in Pharmaceutical Development and Manufacturing II

Chair(s)

Co-chair(s)

Marton, C., Bristol Myers Squibb

This sessions highlight the selection and monitoring of critical quality attributes (CQA) to ensure desired performance in drug product during pharmaceutical development and/or manufacturing. The integration of empirical and theoretical process models with a control strategy is a focus of this session. The successes and challenges associated with advanced control strategies, such as model predictive control and multivariate control, are addressed. The scope of this session includes batch, semi-continuous, and continuous processes. Academic and industrial research involving the novel use of Process Analytical Tools for on-line monitoring of CQAs are explored. Applications of lab-based PAT to identify scalable process fingerprint and establish control strategy, as well as advancements in technologies and methods toward real-time monitoring and release are included.

Presentations

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00